Clinical Trials in Almaty, Kazakhstan
Locations / Almaty, Kazakhstan
Delta Trials hosts 125 clinical trials conducted in Almaty, Kazakhstan, making it a notable site of clinical research activity. These trials covering 199 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Almaty.
125
Total Trials
199
Conditions
3
Terminated since 2020
Browse by condition (199 total)
- Breast cancer 5 trialsAll Breast cancer trials
- Tuberculosis, multidrug-resistant 4 trialsAll Tuberculosis, multidrug-resistant trials
- HIV 3 trialsAll HIV trials
- Anxiety 3 trialsAll Anxiety trials
- Schizophrenia 3 trialsAll Schizophrenia trials
- Pulmonary tuberculoses 2 trialsAll Pulmonary tuberculoses trials
- Cancer 2 trialsAll Cancer trials
- Type 2 diabetes 2 trialsAll Type 2 diabetes trials
- Gastric cancer 2 trialsAll Gastric cancer trials
- Intestinal infections 2 trialsAll Intestinal infections trials
- Inflammatory bowel diseases 2 trialsAll Inflammatory bowel diseases trials
- Stigma, social 2 trialsAll Stigma, social trials
- Crohn's disease 2 trialsAll Crohn's disease trials
- Lung cancer 2 trialsAll Lung cancer trials
- Ovarian cancer 2 trialsAll Ovarian cancer trials
- Depression 2 trialsAll Depression trials
- Hypertension 2 trialsAll Hypertension trials
- Induction of labor 2 trialsAll Induction of labor trials
- Hiv testing 2 trialsAll Hiv testing trials
- Dysbacteriosis 2 trialsAll Dysbacteriosis trials